Potential Binding Sites for Taurine on the Insulin Receptor: A Molecular Docking Study

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Taurine is known to enhance insulin action across various physiological states, including diabetes.
• The precise molecular mechanisms underlying taurine's beneficial effects on insulin sensitivity remain incompletely elucidated.
• Insulin receptor (IR) ectodomain (ECD) is crucial for insulin signaling, and its interaction with ligands is key to glucose homeostasis.

Purpose of the Study:

• To investigate whether taurine acts as an agonist for the insulin receptor (IR).
• To identify potential binding sites of taurine on the IR ectodomain (ECD) using in silico methods.
• To elucidate the molecular interactions contributing to taurine's effects on insulin sensitivity.

Main Methods:

• In silico molecular modeling and simulation techniques were employed.
• Analysis of potential ligand-binding pockets within the IR ECD.
• Assessment of taurine's binding affinity and interaction energy with identified pockets.

Main Results:

• Molecular modeling predicted three major ligand-binding pockets in the IR ECD where taurine could interact.
• Taurine exhibited significant binding affinity, with the highest interaction energy observed at pocket 1, followed by pockets 2 and 3.
• The identified taurine binding sites on the IR ECD differ from those of insulin.

Conclusions:

• Taurine likely functions as an agonist of the IR ECD, demonstrating high-affinity binding at pocket 1.
• These findings suggest a novel mechanism for taurine's action on insulin signaling.
• Understanding these interactions may lead to new therapeutic strategies for improving glucose homeostasis and related cellular functions.